SMAD4 and pancreatic neoplasm: Nevertheless, further clinical investigations are necessary to evaluate the correlation between SMAD4 status and the survival advantages of radiotherapy in pancreatic cancer patients, which could potentially help guide the administration of targeted therapies in the adjuvant setting based on SMAD4 status.